Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo-Nordisk's Oral GLP-1 Diabetes Treatment: An Update
Seeking Alpha
Sat, 02/21/15 - 09:38 am
Tags:
Novo Nordisk, diabetes, GLP-1 agonist, semaglutide
Patient groups still think ViiV is tops, with Novo and AbbVie close behind
Fierce Pharma Marketing
Wed, 02/11/15 - 09:47 am
Tags:
ViiV, Novo Nordisk, AbbVie, patients
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
Tags:
R&D, Merck, Novo Nordisk, Amgen, Sanofi, Ono Pharmaceutical
Sanofi undertakes major sales reorg of US diabetes business
BioPharma Dive
Tue, 02/10/15 - 10:39 am
Tags:
Sanofi, Novo Nordisk, diabetes, reorganization
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
Tags:
patents, Big Pharma, Abilify, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Crestor, Eli Lilly, Gilead Sciences, GSK, Harvoni, Hospira, Merck, Novo Nordisk, Pfizer, Sovaldi, Tecfidera
Novo Nordisk joins pharma's IPO clique with plans for tech subsidiary spinoff
Fierce Pharma
Mon, 02/9/15 - 10:35 am
Tags:
Novo Nordisk, IPOs, spinoffs, NNIT
Forget Pfizer! This Big Pharmaceutical Stock is Better
Motley Fool
Sun, 02/8/15 - 10:03 am
Tags:
Pfizer, Novo Nordisk
Moody's: Patent-cliff challenges will continue to dog big pharma
BioPharma Dive
Wed, 02/4/15 - 01:43 pm
Tags:
patents, patent cliff, Big Pharma, Pfizer, Eli Lilly, Merck, Amgen, Novo Nordisk, AstraZeneca, Bristol-Myers Squibb
Victoza powers Novo's strong year; CEO projects growth for 2015
Fierce Pharma
Fri, 01/30/15 - 11:15 am
Tags:
Novo Nordisk, earnings, Pharma CEOs, Victoza, Lars Sorenson
Novo Nordisk puts 500 Saxenda reps on U.S. streets, aiming for $1B in weight-loss sales
Fierce Pharma
Tue, 01/27/15 - 08:41 am
Tags:
Novo Nordisk, Saxenda, drug reps
Novo Nordisk stock rises on $2 billion buyback
Marketwatch
Mon, 01/26/15 - 08:10 am
Tags:
Novo Nordisk, stock buybacks
Novo Nordisk Plans to Move Forward With Investments in Russia
Bloomberg
Fri, 01/23/15 - 08:32 am
Tags:
Novo Nordisk, Russia
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
Tags:
obesity, Orexigen, Contrave, Arena Pharmaceuticals, Belviq, APD334, Vivus, Qsymia, EnteroMedics, devices, Maestro System, Novo Nordisk, Saxenda
Next-Generation Diabetes Drug Offers Great Growth Potential
Motley Fool
Sat, 01/10/15 - 01:11 pm
Tags:
diabetes, Novo Nordisk, Perle Biosciences, PRL001, PRL002, JNJ, AstraZeneca, Bristol-Myers Squibb
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:23 pm
Tags:
Actavis, Celgene, Amgen, AbbVie, Gilead Sciences, Eli Lilly, Novartis, AstraZeneca, Merck, JNJ, Biogen Idec, Novo Nordisk, Roche, Bristol-Myers Squibb, Pfizer, GSK, Sanofi
Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares
Yahoo/Globe NewsWire
Sat, 01/3/15 - 10:58 am
Tags:
Novo Nordisk
Novo Nordisk to promote drug to treat obesity in United States
Yahoo/Reuters
Mon, 12/29/14 - 11:13 am
Tags:
Novo Nordisk, obesity, Saxenda
Novo Nordisk CEO Speaks Of Short-Term Challenges That Could Limit Growth
Bidness Etc.
Mon, 12/29/14 - 11:03 am
Tags:
Novo Nordisk, Pharma CEOs, insulin, Tresiba, Lars Sorenson
Novo Nordisk CEO sees short-term challenges to growth - paper
Yahoo/Reuters
Sat, 12/27/14 - 10:33 am
Tags:
Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.